Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-19-055735

Chief Financial Officer acquired 12,649 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Myszkowski Kenneth Allen Chief Financial Officer 2019-11-05 Option exercise +12,649 $5.19 $65,648 326,185 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Myszkowski Kenneth Allen Chief Financial Officer 2019-11-05 Option exercise · Stock Option (right to buy) −12,649 149,467 D: show line 2 in the form
Loading xslF345X03/doc4.xml…